‘Pay for Delay’ Ruling

The U.S. Supreme Court ruled Monday that the government can challenge the so-called “pay for delay” deals—deals that pharmaceutical companies make with generic drug companies to delay releasing their less expensive, generic drugs. Hampton Pearson has the story for NBR.